PeptideHelper.org
An evidence-based peptide reference
Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology

Research Focus Area

Peptides studied in Growth Hormone Secretion research

Growth Hormone Secretion is a peptide research focus area. PeptideHelper.org catalogues compounds studied for this area with evidence tier, regulatory status, mechanism, and dosing reference for each.

Peptides studied for Growth Hormone Secretion (19)

Ranked by evidence tier first, then editorial popularity. "Studied for" describes published research focus, not clinical recommendation.

  1. Tesamorelin , GHRH analog (FDA-approved) · FDA-Approved · Prescription · 165 citations
    Reduces visceral abdominal fat (HIV lipodystrophy); lowers triglycerides; modest IGF-1 rise
  2. Somatropin (HGH) , Recombinant human growth hormone · FDA-Approved · Prescription · 245 citations
    Direct GH effects; lean mass; fat loss; bone density; approved for GHD/Turner/etc.
  3. Tesamorelin + Ipamorelin , FDA-approved GHRH analog (Tesamorelin) + selective GHRP (Ipamorelin) blend · FDA-Approved (component) · Compounding Restricted · 2 citations
    Visceral adiposity reduction (Tesamorelin signal); improved sleep and recovery; cleaner side-effect profile than CJC-DAC blends; favoured for HIV-lipodystrophy-adjacent body composition goals
  4. MK-677 , Oral non-peptide ghrelin receptor agonist · Phase 3 (not approved) · Research Chemical · 168 citations
    Increased GH/IGF-1; improved sleep; lean mass; bone density
  5. CJC-1295 , GHRH analog (no-DAC or DAC forms) · Anecdotal + Phase 2 (DAC) · Compounding Restricted · 57 citations
    GH/IGF-1 elevation; lean mass; recovery; improved sleep; extended half-life with DAC
  6. Ipamorelin , Growth hormone-releasing peptide (GHRP); ghrelin receptor agonist · Anecdotal + Phase 2 · Compounding Restricted · 91 citations
    Clean GH release without cortisol/prolactin rise; minimal hunger; lean mass; recovery
  7. Hexarelin , GHRP; potent ghrelin receptor agonist · Phase 2 (not approved) · Research Chemical · 196 citations
    Very potent GH release; cardioprotective (preclinical); muscle
  8. IGF-1 LR3 , IGF-1 analog (extended half-life); anabolic · Anecdotal + Animal Studies · Research Chemical · 65 citations
    Muscle hyperplasia and growth; cellular proliferation; nutrient partitioning
  9. GHRP-6 , GHRP; ghrelin receptor agonist · Anecdotal + Animal Studies · Research Chemical · 200 citations
    GH release; significant appetite stimulation; muscle building
  10. IGF-1 DES , IGF-1 analog (truncated); anabolic · Anecdotal + Animal Studies · Research Chemical · 113 citations
    Localized muscle hyperplasia; more potent than native IGF-1
  11. CJC-1295 + Ipamorelin , GHRH analog + selective GHRP blend (GH-secretagogue stack) · Anecdotal + Animal Studies · Compounding Restricted · 6 citations
    Layered pituitary GH release; improved sleep architecture; recovery and lean body composition support; lower cortisol/prolactin signal than GHRH + GHRP-6 alternatives
  12. MGF , IGF-1 splice variant peptide; anabolic · Preclinical + Anecdotal · Research Chemical · 270 citations
    Satellite cell activation; local muscle repair; hyperplasia
  13. PEG-MGF , Pegylated IGF-1 splice variant; anabolic · Anecdotal · Research Chemical · 16 citations
    Systemic muscle repair signaling; longer action vs MGF
  14. Hulk Stack , GH + IGF stack: GHRH analog + selective GHRP + long-acting IGF-1 analog · Anecdotal · Compounding Restricted
    Muscle accrual and recovery support through layered GH + IGF action; reported effects include improved recovery and lean-mass gain during dosing cycles
  15. Follistatin , Myostatin-binding glycoprotein; anabolic · Preclinical + Gene Therapy Trials · Research Chemical · 273 citations
    Myostatin/activin inhibition; muscle hypertrophy potential
  16. Follistatin 315 , Follistatin isoform; anabolic · Preclinical · Research Chemical · 75 citations
    Systemic myostatin inhibition; lean mass preservation
  17. Follistatin 344 , Follistatin isoform; anabolic · Preclinical · Research Chemical · 32 citations
    Local muscle myostatin inhibition; hypertrophy research
  18. GHRP-2 , GHRP; ghrelin receptor agonist · Japan-Approved Diagnostic · Research · 215 citations
    Strong GH release; some appetite increase; lean mass
  19. Sermorelin , GHRH analog · Discontinued (FDA approval 1990; US withdrawal 2008) · Compounding Restricted · 247 citations
    Pulsatile GH/IGF-1 stimulation; sleep quality; anti-aging

Stacks targeting Growth Hormone Secretion

Frequently asked questions

What peptides are most studied for Growth Hormone Secretion?

On PeptideHelper.org, the top compounds in this area by evidence tier and popularity are: Tesamorelin, Somatropin (HGH), Tesamorelin + Ipamorelin. The full ranked list is below.

Are any Growth Hormone Secretion peptides FDA-approved?

3 compounds in this area are FDA-approved: Tesamorelin, Somatropin (HGH), Tesamorelin + Ipamorelin.

What peptide stacks target Growth Hormone Secretion?

Stacks discussed in research and practitioner literature for this area include: Gold Standard GH, Fat Loss GH. Each stack page details the components, mechanism, and typical use.

How are peptides for Growth Hormone Secretion ranked on PeptideHelper.org?

Compounds are ranked first by evidence tier (FDA-approved, then Phase 3, Phase 2, Phase 1, animal studies, anecdotal), then by editorial popularity rank within the same tier.

Open the PeptideHelper.org goal evaluator to filter by goal, evidence tier, and regulatory status interactively.

Loading interactive view…